Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells

Two major barriers in the immunotherapy of breast cancer include tumor-induced immune suppression and the establishment of long-lasting immune responses against the tumor. Recently, we demonstrated in an animal model of breast carcinoma that expanding and reprogramming tumor-sensitized lymphocytes,...

Full description

Saved in:
Bibliographic Details
Published in:Breast Cancer Res Treat
Main Authors: Payne, Kyle K, Zoon, Christine K, Wan, Wen, Marlar, Khin, Keim, Rebecca C, Kenari, Mehrab Nasiri, Kazim, A Latif, Bear, Harry D, Manjili, Masoud H
Format: Artigo
Language:Inglês
Published: 2013
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4844228/
https://ncbi.nlm.nih.gov/pubmed/24197563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-013-2733-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items